Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2000

View Archived Issues

BioCryst strengthens drug candidate pipeline

Proteasome inhibitor PS-519 protective in cerebral ischemia model

GABA-B antagonist CGP-36742 promnestic in epilepsy model

NIH to conduct trials of potential new transplant therapy for diabetes

Incyte and Elitra establish antimicrobial genomics alliance

FDA approves Glucovance for treatment of type 2 diabetes

CRF1 receptor antagonist displays safety and efficacy in clinical trial

Research advances the use of transgenic plants to deliver vaccines

CGS-21680 promising agent for myocardial perfusion imaging

PR-000350 shows promise in improving efficacy of radiation therapy

Allovectin-7 phase I/II data released

Aventis seeks approval of Dynepo in U.S. and Europe

Icos and Array BioPharma expand collaboration

AMBI licenses nisin and lysostaphin to Biosynexus

Ginkgo biloba extract shows promise as treatment for dementia

Novel arylpiperazines assessed as uroselective agents for BPH

Once-daily postoperative dosing approved for Fragmin

Forest licenses dexloxiglumide from Rotta for treatment of IBS

New serine protease inhibitors useful for thromboembolic disorders

New serine protease inhibitors useful for treating cancer

New HIV integrase inhibitors under study at Merck & Co.

DNA topoisomerase II inhibitors under study at Lafon

New alpha4-integrin antagonists useful for asthma, etc.

New IL-5 inhibitors under development at Janssen

New antimicrobial agents under development at SmithKline Beecham

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...